IMA Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.16M | Sell |
9,910
-273
| -3% | -$60.6K | 0.21% | 88 |
|
|
2025
Q4 | $2.33M | Sell |
10,183
-224
| -2% | -$51K | 0.22% | 86 |
|
|
2025
Q3 | $2.41M | Sell |
10,407
-174
| -2% | -$35.4K | 0.24% | 76 |
|
|
2025
Q2 | $1.96M | Buy |
10,581
+178
| +2% | +$33.1K | 0.21% | 82 |
|
|
2025
Q1 | $2.18M | Sell |
10,403
-369
| -3% | -$71.7K | 0.26% | 71 |
|
|
2024
Q4 | $1.91M | Buy |
10,772
+170
| +2% | +$31.3K | 0.23% | 86 |
|
|
2024
Q3 | $2.09M | Buy |
10,602
+89
| +0.8% | +$16.6K | 0.46% | 71 |
|
|
2024
Q2 | $1.8M | Sell |
10,513
-259
| -2% | -$42.9K | 0.8% | 44 |
|
|
2024
Q1 | $1.96M | Sell |
10,772
-1,011
| -9% | -$174K | 0.93% | 37 |
|
|
2023
Q4 | $1.83M | Sell |
11,783
-1,077
| -8% | -$157K | 0.91% | 37 |
|
|
2023
Q3 | $1.92M | Sell |
12,860
-719
| -5% | -$106K | 0.5% | 63 |
|
|
2023
Q2 | $1.83M | Sell |
13,579
-376
| -3% | -$55.1K | 0.47% | 68 |
|
|
2023
Q1 | $2.22M | Buy |
13,955
+896
| +7% | +$137K | 0.57% | 54 |
|
|
2022
Q4 | $2.11M | Sell |
13,059
-161
| -1% | -$24.7K | 0.56% | 54 |
|
|
2022
Q3 | $1.77M | Sell |
13,220
-252
| -2% | -$36.2K | 0.48% | 61 |
|
|
2022
Q2 | $2.06M | Buy |
13,472
+89
| +0.7% | +$13.6K | 0.5% | 62 |
|
|
2022
Q1 | $2.17M | Sell |
13,383
-3,477
| -21% | -$505K | 0.5% | 67 |
|
|
2021
Q4 | $2.28M | Sell |
16,860
-4,545
| -21% | -$537K | 0.5% | 72 |
|
|
2021
Q3 | $2.31M | Sell |
21,405
-44
| -0.2% | -$5.03K | 0.55% | 65 |
|
|
2021
Q2 | $2.42M | Buy |
21,449
+313
| +1% | +$35.3K | 0.56% | 66 |
|
|
2021
Q1 | $2.29M | Buy |
21,136
+916
| +5% | +$98K | 0.56% | 68 |
|
|
2020
Q4 | $2.17M | Buy |
20,220
+660
| +3% | +$63.4K | 0.61% | 61 |
|
|
2020
Q3 | $1.71M | Buy |
19,560
+523
| +3% | +$49.2K | 0.57% | 59 |
|
|
2020
Q2 | $1.87M | Sell |
19,037
-6,369
| -25% | -$561K | 0.68% | 55 |
|
|
2020
Q1 | $1.94M | Sell |
25,406
-3,948
| -13% | -$336K | 0.85% | 41 |
|
|
2019
Q4 | $2.6M | Sell |
29,354
-2,054
| -7% | -$171K | 0.96% | 44 |
|
|
2019
Q3 | $2.38M | Buy |
31,408
+1,996
| +7% | +$137K | 0.9% | 48 |
|
|
2019
Q2 | $2.14M | Buy |
29,412
+2,833
| +11% | +$223K | 0.8% | 56 |
|
|
2019
Q1 | $2.14M | Buy |
26,579
+6,978
| +36% | +$571K | 0.83% | 54 |
|
|
2018
Q4 | $1.81M | Sell |
19,601
-18
| -0.1% | -$1.58K | 0.84% | 44 |
|
|
2018
Q3 | $1.86M | Buy |
19,619
+738
| +4% | +$70K | 0.73% | 57 |
|
|
2018
Q2 | $1.75M | Buy |
18,881
+3,734
| +25% | +$365K | 0.73% | 55 |
|
|
2018
Q1 | $1.43M | Sell |
15,147
-1,141
| -7% | -$125K | 0.64% | 66 |
|
|
2017
Q4 | $1.57M | Sell |
16,288
-13
| -0.1% | -$1.23K | 0.7% | 58 |
|
|
2017
Q3 | $1.45M | Buy |
16,301
+2
| +0% | +$152 | 0.67% | 58 |
|
|
2017
Q2 | $1.18M | Sell |
16,299
-1,685
| -9% | -$113K | 0.57% | 66 |
|
|
2017
Q1 | $1.17M | Buy |
17,984
+2,367
| +15% | +$149K | 0.59% | 60 |
|
|
2016
Q4 | $978K | Sell |
15,617
-2,919
| -16% | -$178K | 0.6% | 57 |
|
|
2016
Q3 | $1.17M | Sell |
18,536
-342
| -2% | -$22.1K | 0.67% | 52 |
|
|
2016
Q2 | $1.17M | Buy |
18,878
+1,110
| +6% | +$67.6K | 0.73% | 52 |
|
|
2016
Q1 | $1M | Sell |
17,768
-656
| -4% | -$36.6K | 0.58% | 63 |
|
|
2015
Q4 | $1.08M | Buy |
18,424
+1,283
| +7% | +$73.9K | 0.65% | 50 |
|
|
2015
Q3 | $920K | Sell |
17,141
-1,300
| -7% | -$84.6K | 0.58% | 56 |
|
|
2015
Q2 | $1.24M | Sell |
18,441
-885
| -5% | -$57.8K | 0.59% | 50 |
|
|
2015
Q1 | $1.13M | Buy |
19,326
+1,145
| +6% | +$69.2K | 0.55% | 52 |
|
|
2014
Q4 | $1.19M | Buy |
18,181
+70
| +0.4% | +$4.41K | 0.61% | 53 |
|
|
2014
Q3 | $1.05M | Hold |
18,111
| – | – | 0.49% | 62 |
|
|
2014
Q2 | $1.02M | Sell |
18,111
-11,180
| -38% | -$587K | 0.47% | 62 |
|
|
2014
Q1 | $1.51M | Sell |
29,291
-930
| -3% | -$47K | 0.7% | 48 |
|
|
2013
Q4 | $1.6M | Buy |
30,221
+3,541
| +13% | +$174K | 0.76% | 43 |
|
|
2013
Q3 | $1.19M | Buy |
26,680
+6,894
| +35% | +$306K | 0.59% | 51 |
|
|
2013
Q2 | $818K | Buy |
+19,786
| New | +$865K | 0.44% | 80 |
|
Other funds holding ABBV
VCM
VPM
IMA Advisory Services's ABBV Position: Q1 2026 in Review
IMA Advisory Services reduced its AbbVie (ABBV) stake by 2.7% in Q1 2026, selling an estimated $60.6K and leaving 9,910 shares worth $2.16M. The position accounts for 0.21% of the portfolio, ranked #88.
IMA Advisory Services first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.6M in Q4 2019. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- IMA Advisory Services held 9,910 shares of AbbVie worth $2.16M as of Q1 2026.
- IMA Advisory Services sold 273 AbbVie shares in Q1 2026, an estimated $60.6K.
- AbbVie made up 0.21% of IMA Advisory Services's portfolio in Q1 2026, its #88 holding.
- IMA Advisory Services first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- IMA Advisory Services's AbbVie position peaked at $2.6M in Q4 2019.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.